Showing results (121-130 of 207) with videos related to
Sort By:
Pageof 21
European Heart Journal|September 3, 2025
Clinical care of family members of patients with dilated cardiomyopathyJob A J Verdonschot, Juan Pablo Kaski, Folkert W Asselbergs, et al.Journal of the American College of Cardiology|January 28, 2012
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort studyIngrid A W van Rijsingen, Eloisa Arbustini, Perry M Elliott, et al.Heart Rhythm|November 3, 2009
Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES geneJ Peter van Tintelen, Isabelle C Van Gelder, Angeliki Asimaki, et al.Circulation. Genomic and Precision Medicine|August 7, 2019
Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De NovoFreyja H M van Lint, Brittney Murray, Crystal Tichnell, et al.Heart Rhythm|November 4, 2024
Long-term prognosis of patients with an SCN5A loss-of-function variant and progressive cardiac conduction disorder or Brugada syndromeFenna Tuijnenburg, Virginnio M Proost, Aurélie Thollet, et al.Circulation. Genomic and Precision Medicine|January 26, 2019
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy GenesJodie Ingles, Jennifer Goldstein, Courtney Thaxton, et al.Circulation|March 29, 2006
Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathyJ Peter van Tintelen, Mark M Entius, Zahurul A Bhuiyan, et al.Circulation|June 17, 2025
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular CardiomyopathySteven A Muller, Babken Asatryan, Alessio Gasperetti, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 9, 2018
Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathyJohanna C Herkert, Kristin M Abbott, Erwin Birnie, et al.International Journal of Cardiology|October 18, 2012
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complicationsIngrid A W van Rijsingen, Annemieke Bakker, Donija Azim, et al.Pageof 21